New diabetes research is seeking to develop a radical new vaccine style therapy for diabetes . A research team at the Children’s Hospital of Pittsburgh will seek to apply the vaccine to children recently diagnosed with type 1 diabetes .
The vaccine functions by curbing the rogue immune cells that cause type 1 diabetes, before patients have to start daily insulin injections . The researchers say that treating children at onset is the best chance possible.
Type 1 diabetes is much less common than type 2 diabetes, but it requires daily insulin injections to stay alive. The research is being conducted by an immunologist at Pittsburgh, Dr. Massimo Trucco. The vaccine is manufactured using the patients’ own blood .
Diabetes experts throughout the world praised the potential of the project.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…